Literature DB >> 6239588

Case report: clinical pathological correlations in a case of primary parathyroid carcinoma.

M S Laks, S E Kahn, M J Favus, E W Bermes.   

Abstract

Carcinoma of parathyroid accounts for one to two percent of patients with primary hyperparathyroidism. A patient admitted to our medical center gave us the opportunity to follow the course of the clinical laboratory findings and the effect of treatment modalities on these laboratory measurements. The clinical course included hypercalcemia, hypophosphatemia, pancreatitis, consumptive coagulopathy, pancytopenia, and sepsis. As vitamin D3 plays and important role in calcium homeostasis, 1,25-(OH)2- vitamin D3 was measured at several points during the clinical course. These finding may serve to help understand some of the underlying control mechanisms involved in the hypercalcemic state.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239588

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  4 in total

Review 1.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

Review 2.  Diagnosis and treatment of patients with parathyroid carcinoma: an update and review.

Authors:  T Obara; Y Fujimoto
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

3.  Normocalcemic parathyroid carcinoma: an unusual clinical presentation.

Authors:  Corrie L Messerer; Samuel P Bugis; Chris Baliski; Sam M Wiseman
Journal:  World J Surg Oncol       Date:  2006-02-21       Impact factor: 2.754

Review 4.  Acute pancreatitis as an initial manifestation of parathyroid carcinoma: A case report and literature review.

Authors:  Yuan Gao; Cheng Yu; Feixiang Xiang; Mingxing Xie; Lingyun Fang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.